本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Castle Biosciences, Inc.

39.44
-0.1600-0.40%
盤後38.66-0.7800-1.98%19:34 EST
成交量:36.16萬
成交額:1,425.76萬
市值:11.51億
市盈率:-90.84
高:39.87
開:39.46
低:39.15
收:39.60
52周最高:40.61
52周最低:14.59
股本:2,918.87萬
流通股本:2,672.49萬
量比:1.02
換手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-0.4342
每股收益(LYR):0.6569
淨資產收益率:-2.69%
總資產收益率:-1.72%
市淨率:2.46
市盈率(LYR):60.04

資料載入中...

2025/08/04

重要事件披露

Form 8-K - Current report
2025/06/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/23

重要事件披露

Form 8-K - Current report
2025/05/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/05

重要事件披露

Form 8-K - Current report
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]